Monoprost (Latanoprost)

Latanoprost activates prostaglandin F receptors in the ciliary body, remodeling extracellular matrix and enhancing uveoscleral outflow of aqueous humor, which reduces intraocular pressure and slows glaucoma progression.

The dosing regimen for Monoprost is determined by the prescribing clinician. Typically, one drop is instilled into the affected eye(s) once daily in the evening, but exact instructions must follow the prescriber’s order.

The safety of latanoprost in pregnancy and lactation has not been established. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and the prescriber should evaluate each case individually.

To request Monoprost, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Monoprost belongs to the prostaglandin analog class, which generally offers once‑daily dosing and strong intraocular pressure reduction. Compared with beta‑blocker drops, prostaglandin analogs often have a more favorable dosing schedule and fewer systemic side effects, though they may cause ocular changes such as iris darkening.

Monoprost should be stored at room temperature, below 25 °C, in its original container. Keep the bottle tightly closed, protect it from light, and avoid freezing. Do not refrigerate unless specifically instructed by the supplier.

Monoprost is applied as a single ophthalmic drop to the affected eye(s) once daily, usually in the evening. The patient should wash hands, avoid touching the tip of the bottle to the eye or any surface, and gently close the eye after instillation.

Serious risks include uveitis or severe intraocular inflammation, allergic reactions such as eyelid swelling, and rare cases of macular edema. Patients should report any sudden eye pain, vision changes, or signs of infection to their eye care professional promptly.

Monoprost is contraindicated in patients with active ocular infections or inflammation, hypersensitivity to latanoprost or any component of the formulation, and should be used with caution in individuals with a history of severe ocular inflammation.